STOCK TITAN

AbbVie to Present at the Wolfe Research Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on November 17, 2021, at 8:30 a.m. Central time. Key executives including Dr. Michael Severino, Robert A. Michael, and Jeffrey R. Stewart will present at the event. A live audio webcast will be available on AbbVie's Investor Relations website, with an archived version accessible later the same day. AbbVie's mission focuses on delivering innovative medicines in various therapeutic areas, including immunology, oncology, and more.

Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., Nov. 10, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on Wednesday, November 17, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 8:30 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-wolfe-research-healthcare-conference-301420573.html

SOURCE AbbVie

FAQ

What is AbbVie's participation in the Wolfe Research Healthcare Conference?

AbbVie will present at the Wolfe Research Healthcare Conference on November 17, 2021, at 8:30 a.m. Central time.

Who will represent AbbVie at the Wolfe Research Healthcare Conference?

Representatives include Dr. Michael Severino, Robert A. Michael, and Jeffrey R. Stewart.

Where can I watch AbbVie's presentation at the Wolfe Research Conference?

The presentation will be accessible via AbbVie's Investor Relations website.

What is AbbVie's mission?

AbbVie's mission is to deliver innovative medicines addressing serious health issues across multiple therapeutic areas.

What are the key therapeutic areas AbbVie focuses on?

AbbVie focuses on immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

339.90B
1.77B
0.1%
73.48%
0.99%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NORTH CHICAGO